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UGDH (OMIM603370) encodes an oxidoreductase that converts UDP-glucose to UDP-glucuronate, used in glycosaminoglycans biosynthesis. UGDH knockout leads to severe, but distinct developmental abnormalities in several animal models; however no germline mutation has been reported in human yet.
Using patients' fibroblasts harboring the p.Ala82Thr mutation, we show that it does not alter UGDH mRNA expression, but that its protein level is decreased relative to control cells. Biochemically, UGDHA82T was unable to form hexamers like UGDHWT and was more prone to proteolysis. Consistently, NADH enzymatic reduction by UGDHA82T was significantly decreased relative to UGDHWT.
To confirm the A82T pathogenicity in vivo, we performed rescue experiments using jekyll zebrafish embryos that carry a mutation in the ugdh gene. Interestingly, ugdhWT mRNA injection was able to fully rescue the jekyll phenotype, while ugdhA82T mRNA injection failed to do so.
In the brain, hyaluronan is the major glycosaminoglycan of the extracellular matrix and its deficiency in mice leads to altered neuronal activity and seizures. We thus hypothesize that a deficiency in UGDH activity might give rise to a deficit in hyaluronan production in the developing brain, which could explain the phenotypes of this hitherto undescribed syndrome. Diabetes mellitus is a group of chronic metabolic disorders characterized by inappropriate hyperglycemia. It has been estimated that this disease will affect 7.8% of the world adult population by 2030. Diabetic cardiomyopathy is the leading cause contributing to the increased morbidity and mortality in diabetic patients. Endothelial dysfunction has been reported in diabetic animal models and patients to induce cardiac remodeling and dysfunction. However, the mechanisms by which hyperglycemia induces endothelial dysfunction are not fully understood and currently no specific therapy is available. We and others have demonstrated the cardioprotective role of follistatin-like 1 (FSTL1) under various pathological stresses, including excessive nitric oxide, myocardial infarction, ischemic reperfusion, and pressure overload. However, whether FSTL1 mediates cytoprotection against hyperglycemia-induced endothelial dysfunction remains to be further elucidated. Human umbilical vein endothelial cells (HUVECs) were cultured in endothelial growth medium-2 (EGM-2) (normal glucose, NG). In the high glucose (HG)-treated group, cells were incubated with EBM-2 containing an extra 25 mM of D-glucose. We demonstrated that FSTL1 treatment significantly attenuates hyperglycemia-induced tube formation and migration disability of endothelial cells. Our study provides novel insights into the cardioprotective role of FSTL1 on hyperglycemiainduced endothelial dysfunction. Liver fibrosis is the scarring process that represents the liver's intrinsic response to injury. This gradual scarring of the liver puts people at risk to develop liver cirrhosis and liver cancer. We have identified several patients from two families with chronic liver fibrosis that is caused by homozygous loss of function mutations in a Protein Disulfide Isomerase (PDI). This family of enzymes resides in the endoplasmic reticulum (ER) and is important for the proper folding of proteins via disulfide bridging. Mutation from one family results in a protein null while the other results in loss of PDI enzymatic activity. Characterization of patient fibroblasts show elevated expression of ER stress genes. Loss of PDI activity is known to cause protein misfolding. Accumulation of misfolded proteins can activate the ER stress mechanism which aims to restore ER homeostasis or initiate cell death. This PDI is expressed in both hepatocytes and hepatic stellate cells in the human liver. Knockdown of PDI in immortalized hepatocytes increases the expression of ER stress genes. Previous studies have implicated ER stress in contributing to fibrosis. Together, our data suggests that increased ER stress may be a mechanism that contributes to the initiation and progression of liver fibrosis. Robinow Syndrome is characterized by 'fetal facies' and is caused by mutations in the WNT5A ligand, the adaptor protein DVL or the receptor ROR2. Patients typically have a wider midface which suggests that embryonic facial narrowing was disrupted. In order to model Robinow syndrome we inserted mutant genes into the chicken embryo face. We knocked in C-terminal nonsense mutations into human Dishevelled 1 that cause autosomal dominant Robinow Syndrome (DRS2, OMIM 616331). Either wild-type or mutant DVL1 constructs were cloned into RCAS retroviruses and injected into the stage 15 frontonasal mass. External phenotypes: by stage 29-30 the egg tooth formed in all embryos indicating that epithelialmesenchymal interactions were unaffected. The frontonasal mass was broader than normal and shorter in sagittal plane (8/12). At stage 38, there was significant upper beak shortening for 1519ΔT, 1529ΔG (6/7 and 13/14). In contrast, the wtDVL1 embryos had mild deviations (9/25) or were normal (15/25). Molecular results: There were no changes in proliferation 48h post-infection. However, there were many changes in gene expression at 48h that were specific to mutant DLV1. AXIN2, LEF1, BMP2, SOX9 and ROR2, WNT5A, Prickle, ALX1 and ALX4 were downregulated in DVL1
1519ΔT infected embryos.
In contrast, ROR2, SOX9 and VANGL2 were increased in wtDVL1. These gene differences reduce the likelihood that phenotypes are only due Abstracts S27
